Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
matthew.brook@nds.ox.ac.uk

lOCATION:

John Radcliffe Hospital, Level 6, Headley Way, Headington, Oxford, OX3 9DU

Research groups

Translational Research Immunology Group (TRIG)

Matthew Brook

NIHR Academic Clinical Lecturer

Recent publications

Regulatory T cell therapy is associated with distinct immune regulatory lymphocytic infiltrates in kidney transplants.
Journal article

McCallion O. et al, (2025), Med, 6
A case of disseminated autochthonous Cladophialophora bantiana infection in a renal transplant recipient in the UK.
Journal article

Mackrill SW. et al, (2024), Lancet Infect Dis
Late Treatment With Autologous Expanded Regulatory T-cell Therapy After Alemtuzumab Induction Is Safe and Facilitates Immunosuppression Minimization in Living Donor Renal Transplantation.
Journal article

Brook MO. et al, (2024), Transplantation, 108, 2278 - 2286
A GMP Protocol for the Manufacture of Tregs for Clinical Application.
Chapter

O'Neil A. et al, (2023), 2559, 205 - 227
Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients.
Journal article

Brook MO. et al, (2022), BMJ Open, 12

More publications